Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Jaramillo-Valverde

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Frontiers in Bioscience (Scholar Edition)|October 11, 2025
Exploratory Study on Genetic Variants Related to Hydatidosis Susceptibility and Albendazole Pharmacogenetics in the Cusco Region in PeruLuis Jaramillo-Valverde, Marlon Yuri Garcia-Paitan, Dolly Landeo, et al.
Pharmacology Research & Perspectives|June 15, 2025
Pharmacogenetic Study of Anti-TB Drugs in the Native Ancestry Peruvian PopulationLuis Jaramillo-Valverde, Mary K Horton, Julio A Poterico, et al.
Frontiers in Bioscience (Scholar Edition)|July 7, 2026
Correction: Jaramillo-Valverde <i>et al</i>. Exploratory Study on Genetic Variants Related to Hydatidosis Susceptibility and Albendazole Pharmacogenetics in the Cusco Region in Peru. 2025; 17(3): 40566Luis Jaramillo-Valverde, Marlon Yuri Garcia-Paitan, Dolly Landeo, et al.
Microorganisms|June 28, 2023
Antigen-Induced IL-1RA Production Discriminates Active and Latent Tuberculosis InfectionCesar Sanchez, Luis Jaramillo-Valverde, Silvia Capristano, et al.
International Journal of Molecular Sciences|February 27, 2026
Molecular Epidemiology of <i>GSTM1</i> and <i>GSTT1</i> Null Genotypes in High-Altitude Andean Populations of PeruMarlon Garcia-Paitan, Carlos Campos-Semino, Zoila Cansinos-Delgado, et al.
Pharmacology Research & Perspectives|April 26, 2024
Pharmacogenetic variability of tuberculosis biomarkers in native and mestizo Peruvian populationsLuis Jaramillo-Valverde, Kelly S Levano, David D Tarazona, et al.
Cureus|February 3, 2022
CXCR4 Knockdown Via CRISPR/CAS9 in a Tumor-Associated Macrophage Model Decreases Human Breast Cancer Cell MigrationLuis Jaramillo-Valverde, Kelly S Levano, Silvia Capristano, et al.
International Journal of Molecular Sciences|October 14, 2022
<i>GSTT1/GSTM1</i> Genotype and Anti-Tuberculosis Drug-Induced Hepatotoxicity in Peruvian PatientsLuis Jaramillo-Valverde, Kelly S Levano, David D Tarazona, et al.
Molecular Genetics & Genomic Medicine|August 30, 2019
Guillain-Barre syndrome outbreak in Peru: Association with polymorphisms in IL-17, ICAM1, and CD1Luis Jaramillo-Valverde, Kelly S Levano, Isolina Villanueva, et al.
Molecular Genetics & Genomic Medicine|June 25, 2022
NAT2 and CYP2E1 polymorphisms and antituberculosis drug-induced hepatotoxicity in Peruvian patientsLuis Jaramillo-Valverde, Kelly S Levano, David D Tarazona, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Frontiers in Bioscience (Scholar Edition)|October 11, 2025
Exploratory Study on Genetic Variants Related to Hydatidosis Susceptibility and Albendazole Pharmacogenetics in the Cusco Region in PeruLuis Jaramillo-Valverde, Marlon Yuri Garcia-Paitan, Dolly Landeo, et al.
Pharmacology Research & Perspectives|June 15, 2025
Pharmacogenetic Study of Anti-TB Drugs in the Native Ancestry Peruvian PopulationLuis Jaramillo-Valverde, Mary K Horton, Julio A Poterico, et al.
Frontiers in Bioscience (Scholar Edition)|July 7, 2026
Correction: Jaramillo-Valverde <i>et al</i>. Exploratory Study on Genetic Variants Related to Hydatidosis Susceptibility and Albendazole Pharmacogenetics in the Cusco Region in Peru. 2025; 17(3): 40566Luis Jaramillo-Valverde, Marlon Yuri Garcia-Paitan, Dolly Landeo, et al.
Microorganisms|June 28, 2023
Antigen-Induced IL-1RA Production Discriminates Active and Latent Tuberculosis InfectionCesar Sanchez, Luis Jaramillo-Valverde, Silvia Capristano, et al.
International Journal of Molecular Sciences|February 27, 2026
Molecular Epidemiology of <i>GSTM1</i> and <i>GSTT1</i> Null Genotypes in High-Altitude Andean Populations of PeruMarlon Garcia-Paitan, Carlos Campos-Semino, Zoila Cansinos-Delgado, et al.
Pharmacology Research & Perspectives|April 26, 2024
Pharmacogenetic variability of tuberculosis biomarkers in native and mestizo Peruvian populationsLuis Jaramillo-Valverde, Kelly S Levano, David D Tarazona, et al.
Cureus|February 3, 2022
CXCR4 Knockdown Via CRISPR/CAS9 in a Tumor-Associated Macrophage Model Decreases Human Breast Cancer Cell MigrationLuis Jaramillo-Valverde, Kelly S Levano, Silvia Capristano, et al.
International Journal of Molecular Sciences|October 14, 2022
<i>GSTT1/GSTM1</i> Genotype and Anti-Tuberculosis Drug-Induced Hepatotoxicity in Peruvian PatientsLuis Jaramillo-Valverde, Kelly S Levano, David D Tarazona, et al.
Molecular Genetics & Genomic Medicine|August 30, 2019
Guillain-Barre syndrome outbreak in Peru: Association with polymorphisms in IL-17, ICAM1, and CD1Luis Jaramillo-Valverde, Kelly S Levano, Isolina Villanueva, et al.
Molecular Genetics & Genomic Medicine|June 25, 2022
NAT2 and CYP2E1 polymorphisms and antituberculosis drug-induced hepatotoxicity in Peruvian patientsLuis Jaramillo-Valverde, Kelly S Levano, David D Tarazona, et al.
Pageof 2